Biofrontera Inc. (BFRI) Stock Ticker
Market factors today
Unlock the full BFRI picture
About Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
BFRI stock facts
| Ticker symbol | BFRI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $15.1M |
| CEO | Hermann Lübbert |
| Employees | 89 |
| Headquarters | Woburn, MA, US |
| IPO date | 2021-10-29 |
| Website | www.biofrontera-us.com |
What you can see for BFRI on Tickr
Live BFRI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BFRI report.
Rankings
FAQ
What is the ticker symbol for Biofrontera Inc.?
The ticker symbol for Biofrontera Inc. is BFRI, listed on the NASDAQ.
What is BFRI?
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is…